# US 2003/0073205 A1 · Production of polyketides

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2003/0073205 A1
- Document ID: US20030073205A1
- Status: Published application
- Kind: A1
- Application number: 09/957,483
- Filed: 2001-09-19
- Published: 2003-04-17
- Earliest claimed: 2000-09-14
- Assignees: Kosan Biosciences, Inc.
- Inventors: Robert L. Arslanian; Gary Ashley; Scott Frykman; Bryan Julien; Leonard Katz; Chaitan Khosla; Janice Lau; Peter J. Licari; Rika Regentin; Daniel Santi; Li Tang
- Web page: https://patentgrep.com/patent/US20030073205A1

## CPC

- C07D 405/06: linked by a carbon chain containing only aliphatic carbon atoms
- C07D 313/00: Heterocyclic compounds containing rings of more than six members having one oxygen atom as the only ring hetero atom
- C07D 413/06: linked by a carbon chain containing only aliphatic carbon atoms
- C07D 417/06: linked by a carbon chain containing only aliphatic carbon atoms
- C07D 491/04: Ortho-condensed systems
- C12N 1/20: Bacteria; Culture media therefor
- C12N 1/205: Bacterial isolates
- C12N 9/00: Enzymes; Proenzymes; Compositions thereof (preparations containing enzymes for cleaning teeth A61K8/66, A61Q11/00; medicinal preparations containing enzymes or proenzymes A61K38/43; enzyme containing detergent compositions C11D; {enzymes with nucleic acid structure, e.g. ribozymes, C12N15/113}); Processes for preparing, activating, inhibiting, separating or purifying enzymes (preparation of malt C12C1/00)
- C12N 15/52: Genes encoding for enzymes or proenzymes
- C12N 15/74: Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora
- C12P 17/00: Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms (C12P13/04 - C12P13/24 take precedence)
- C12P 17/16: containing two or more hetero rings {(thiamine open chain analogs C12P17/167, i.e. not condensed among themselves or through a common carbocyclic ring system)}
- C12P 17/167: {Heterorings having sulfur atoms as ring heteroatoms, e.g. vitamin B1, thiamine nucleus and open chain analogs}
- C12P 17/181: {Heterocyclic compounds containing oxygen atoms as the only ring heteroatoms in the condensed system, e.g. Salinomycin, Septamycin}
- C12R 2001/01: Bacteria or Actinomycetales {; using bacteria or Actinomycetales}
- C07D: HETEROCYCLIC COMPOUNDS (macromolecular compounds C08)
- C12N: MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media C12Q1/00)
- C12P: FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE {(brewing of beer C12C; producing vinegar C12J; producing specific peptides or proteins C07K; producing enzymes C12N9/00; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification C12N15/00; measuring or testing processes involving enzymes or microorganisms C12Q; measuring or testing processes involving nucleic acid amplification reactions C12Q1/6844; fermentation processes to form a food composition, A21 or A23; compounds in general, see the relevant compound class, e.g. C01, C07)}
- C12R: INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS

## Abstract

Recombinant Myxococcus host cells can be used to produce polyketides, including epothilone and epothilone analogs that can be purified from the fermentation broth and crystallized.

## Claims

### Claim 1

A recombinant host cell of the suborder Cystobacterineae containing a recombinant expression vector that encodes a heterologous polyketide synthase (PKS) gene and produces a polyketide synthesized by a PKS enzyme encoded on said vector.

### Claim 2 (depends on 1)

The host cell of claim 1 that is selected from the family Myxococcaceae.

### Claim 3 (depends on 1)

The host cell of claim 1 that is selected from the family Cystobacteraceae.

### Claim 4 (depends on 2)

The host cell of claim 2 that is selected from a genus selected from the group consisting of Angiococcus, Myxococcus, and Corallococcus.

### Claim 5 (depends on 3)

The host cell of claim 3 that is selected from a genus selected from the group consisting of Cystobacter, Melittangium, Stigmatella, and Archangium.

### Claim 6 (depends on 4)

The host cell of claim 4 that is selected from the genus Myxococcus.

### Claim 7 (depends on 5)

The host cell of claim 5 that is selected from the genus Stigmatella.

### Claim 8 (depends on 6)

The host cell of claim 6 that is selected from the group consisting of M. stipitatus, M. fulvus, M. xanthus, and M. virescens.

### Claim 9 (depends on 7)

The host cell of claim 7 that is selected from the group consisting of S. erecta, and S. aurantiaca.

### Claim 10 (depends on 8)

The host cell of claim 8 that is Myxococcus xanthus.

### Claim 11 (depends on 1)

A method for producing a polyketide in a host cell of the suborder Cystobacterineae, which polyketide is not naturally produced in said host cell, said method comprising culturing a host cell of claim 1 under conditions such that a PKS gene encoded on the vector is expressed and said polyketide is produced.

### Claim 12 (depends on 1)

The recombinant host cell of claim 1 that produces epothilone or an epothilone derivative.

### Claim 13 (depends on 10)

The host cell of claim 10 that produces epothilone or an epothilone derivative.

### Claim 14 (depends on 13)

The host cell of claim 13 that produces epothilones A, B, C, and D.

### Claim 15 (depends on 14)

The host cell of claim 14 that is Myxococcus xanthus K111-32.25.

### Claim 16 (depends on 14)

The host cell of claim 14 that produces epothilones A and B as major products and epothilones C and D as minor products.

### Claim 17 (depends on 13)

The host cell of claim 13 that produces epothilones C and D as major products.

### Claim 18 (depends on 17)

The host cell of claim 17 that either does not contain an epoK gene or does not express a fully functional epoK gene product.

### Claim 19 (depends on 18)

The host cell of claim 18 that is Myxococcus xanthus K111-40.1.

### Claim 20 (depends on 18)

The host cell of claim 18 that is Myxococcus xanthus K111-72.4.4.

### Claim 21 (depends on 13)

The host cell of claim 13 that contains an epothilone PKS gene in which a coding sequence for a module of said PKS has been altered by mutation, deletion, or replacement.

### Claim 22 (depends on 21)

The host cell of claim 21, wherein said module is extender module 6.

### Claim 23 (depends on 22)

The host cell of claim 22, wherein said module lacks a functional ketoreductase domain and produces a 9-keto epothilone.

### Claim 24 (depends on 21)

The host cell of claim 21, wherein said module is extender module 5.

### Claim 25 (depends on 24)

The host cell of claim 24, wherein said module 5 lacks a functional dehydratase domain and produces a 13-hydroxy epothilone.

### Claim 26 (depends on 21)

The host cell of claim 21, wherein said module is extender module 4.

### Claim 27 (depends on 26)

The host cell of claim 26, wherein said module lacks a functional ketoreductase domain and produces a 13-keto epothilone.

### Claim 28 (depends on 21)

The host cell of claim 21, wherein said module is extender module 2, the coding sequence for the ketosynthase domain has been altered by mutation to change an active site cysteine to another amino acid, and which host cell must be provided a diketide equivalent compound to produce an epothilone or epothilone derivative.

### Claim 29 (depends on 28)

The host cell of claim 28 that is Myxococcus xanthus strain K90-132.1.1.2.

### Claim 30 (depends on 21)

The host cell of claim 21, wherein said module is extender module 1.

### Claim 31 (depends on 30)

The host cell of claim 30, wherein said module has been changed so that it binds an amino acid other than cysteine.

### Claim 32 (depends on 21)

The host cell of claim 21, wherein said module is a loading module.

### Claim 33 (depends on 32)

The host cell of claim 32, wherein said module has been replaced with a module that binds an amino acid.

### Claim 34 (depends on 28)

An epothilone derivative of the formula
53
produced by culturing said host cell of claim 28 with a diketide equivalent compound of the formula
54
where R7 is hydrogen or methyl and Ar is aryl is selected from the group consisting of
55
where R is hydrogen, hydroxy, halogen, amino, C1-C5 alkyl, C1-C5 hydroxyalkyl, C1-C5 alkoxy, and C1-C5 aminoalkyl.

### Claim 35 (depends on 1)

The host cell of claim 1 that further comprises a heterologous gene that encodes for an enzyme selected from the group consisting of an enzyme that transports a compound into said cell that is utilized in biosynthesis of the polyketide, an enzyme that synthesizes a compound utilized in biosynthesis of the polyketide, and an enzyme that phosphopantetheinylates a PKS.

### Claim 36 (depends on 35)

The host cell of claim 35, wherein said enzyme is MatB.

### Claim 37 (depends on 35)

The host cell of claim 35, wherein said enzyme is MatC.

### Claim 38 (depends on 35)

The host cell of claim 35, wherein said enzyme is MtaA.

### Claim 39 (depends on 13)

The host cell of claim 13, wherein said epothilone or epothilone derivative is produced by a PKS gene under the control of a promoter selected from the group consisting of a promoter from an S. cellulosum epothilone PKS gene, a promoter from a myxothiazol biosynthesis gene, a promoter from a TA biosynthesis gene, a pilA promoter, a promoter from a kanamycin resistance conferring gene, and a So ce90 promoter.

### Claim 40

A method for purifying an epothilone from a cell that produces epothilone, said method comprising culturing said cell in the presence of XAD resin, eluting epothilone from said resin, performing a solid phase extraction of epothilone eluted from said resin, and performing chromatography on epothilone resulting from said solid phase extraction.

### Claim 41 (depends on 36)

The method of claim 36 that further comprises a crystallization step.

### Claim 42

Crystalline epothilone D.

### Claim 43

A method for fermentation of a Myxococcus host cell, which method comprises culturing said cell in liquid medium comprising a fatty acid or oil as a carbon source.

### Claim 44 (depends on 43)

The method of claim 43, wherein said fermentation is a fed-batch fermentation.

### Claim 45 (depends on 43)

The method of claim 43, wherein said Myxococcus host cell produces an epothilone or an epothilone derivative.

### Claim 46 (depends on 45)

The method of claim 45, wherein said host cell produces an epothilone derivative that contains an oxazole instead of a thiazole, and said liquid medium comprises L-serine.

### Claim 47

A isolated compound of the formula
56
wherein:
R1, R2, R3, R5, R11, and R12 are each independently hydrogen, methyl or ethyl;
R4, R6 and R9 are each independently hydrogen, hydroxyl, or oxo; alternatively
R5 and R6 together form a carbon carbon double bond;
R7 is hydrogen, methyl, or ethyl;
R8 and R10 are both hydrogen or together form a carbon carbon double bond or an epoxide;
Ar is aryl; and,
W is O or NR13 where R13 is hydrogen, C1-C10 aliphatic, aryl or alkylaryl.
